2008
DOI: 10.3889/mjms.1857-5773.2008.0013
|View full text |Cite
|
Sign up to set email alerts
|

Homocysteinemia and Methylentetrahydrofolate Reductase Gene Mutation as a Risk Factor for Blood Vessel Disease

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 2 publications
0
1
0
Order By: Relevance
“…In majority of cases methylenetetrahydrofolate reductase MTHFR genetic polymorphism is responsible for mild to moderate hyperhomocysteinemia and is one of the rare genetic risk factors that has been proven [8,9]. In this sense, it has been shown that folic acid stabilizes and maintains the function of the mutated enzyme, a fact that can help in eventual treatment of hyperhomocysteinemia.…”
Section: Introductionmentioning
confidence: 99%
“…In majority of cases methylenetetrahydrofolate reductase MTHFR genetic polymorphism is responsible for mild to moderate hyperhomocysteinemia and is one of the rare genetic risk factors that has been proven [8,9]. In this sense, it has been shown that folic acid stabilizes and maintains the function of the mutated enzyme, a fact that can help in eventual treatment of hyperhomocysteinemia.…”
Section: Introductionmentioning
confidence: 99%